doi: 10.3390/diabetology2020004 43 BornerTGeislerCEFortinSMCosgroveRAlsina-FernandezJDograMet al
Avantika Waring, MD, is the Chief Medical Officer at 9amHealth, bringing over fifteen years of clinical and leadership experience
Alpha-linolenic
The temporary program, which runs until the end of 2027, is the first opportunity for most older adults to get GLP-1s, short for glucagon-like peptide-1 receptor agonists, covered by insurance when used strictly for weight loss
Additionally, semaglutides ability to control blood sugar with fewer gastrointestinal side effects compared to metformin makes it an attractive option for some patients
The integration between these datasets was assessed, and genes and lipids were mapped to relevant KEGG metabolic pathways for over-representation analysis, with significance determined by the False Discovery Rate (FDR)